BiotechTube
Home/Aptose Biosciences/Rafael Bejar, M.D., Ph.D.
RB

Rafael Bejar, M.D., Ph.D.

Senior Vice President, Chief Medical Officer

Aptose Biosciences

Therapeutic Areas

Hematologic MalignanciesOncology

Aptose Biosciences Pipeline

DrugIndicationPhase
Tuspetinib (HM43239)Relapsed/Refractory AMLPhase 1/2
Luxeptinib (CG-806)Relapsed/Refractory B-cell malignancies (CLL, NHL)Phase 1a/b

Leadership Team at Aptose Biosciences

WG
William G. Rice, Ph.D.
Chairman of the Board, President & Chief Executive Officer
FP
Fletcher Payne
Senior Vice President, Chief Financial Officer & Chief Business Officer
DR
Denis R. Burger, Ph.D.
Board Member, Lead Director
EM
Erich M. Platzer, M.D., Ph.D.
Board Member
BD
Brian Druker, M.D.
Scientific Advisory Board Member
View full Aptose Biosciences profile